Imurek

Azathioprine, the active ingredient in Imurek, is an antimetabolite presented as an oral formulation for oral use. It is employed to suppress immune activity in patients undergoing organ transplantation, as well as in autoimmune disorders such as rheumatoid arthritis, inflammatory bowel disease, and systemic lupus erythematosus.

GNH USA supplies Imurek as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Azathioprine is used as an immunosuppressive agent in several chronic inflammatory and transplant‑related conditions.

Organ transplantation prophylaxis: prevents graft rejection by inhibiting lymphocyte proliferation. Rheumatoid arthritis: reduces joint inflammation and disease progression. Inflammatory bowel disease (Crohn's disease, ulcerative colitis): maintains remission and controls intestinal inflammation. Systemic lupus erythematosus: helps control systemic autoimmune activity.

Azathioprine may cause a range of adverse reactions, varying from mild to potentially life‑threatening.

Common Side Effects: - Nausea and vomiting - Loss of appetite - Mild leukopenia or neutropenia - Rash or mild skin irritation - Elevated liver enzymes - Fatigue

Serious or Rare Side Effects: - Severe bone marrow suppression leading to pancytopenia - Clinically significant hepatotoxicity - Acute pancreatitis - Increased susceptibility to serious infections - Malignancies such as lymphoma or skin cancer - Severe hypersensitivity reactions including Stevens‑Johnson syndrome

When prescribing azathioprine, clinicians should observe several safety measures to minimize risks.

Monitor blood counts: perform regular complete blood count (CBC) testing to detect leukopenia or anemia. Monitor liver function: assess hepatic enzymes periodically for signs of hepatotoxicity. Avoid use in active infection: defer initiation or adjust dose if patient has uncontrolled infection. Adjust dose in renal or hepatic impairment: reduce dosage according to organ function. Counsel on contraception: advise women of child‑bearing potential to use effective contraception during therapy. Store at room temperature: keep tablets in the original container, protect from moisture and heat.

Azathioprine interacts with several medicines that can alter its efficacy or toxicity.

Major Interactions (Avoid): - Allopurinol: can markedly increase azathioprine toxicity; concurrent use is contraindicated. - Warfarin: azathioprine may enhance anticoagulant effect, raising bleeding risk. - Live vaccines: immunosuppression can lead to uncontrolled infection from live attenuated vaccines.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may increase risk of nephrotoxicity; monitor renal function. - NSAIDs: can potentiate bone marrow suppression; observe blood counts.